Index page for: Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence

Table of Contents Cholesterol-Lowering Clinical Trials: A Historical PerspectiveScott M. GrundyScandinavian Simvastatin Survival Study (4S)Terje R. PedersenThe Cholesterol and Recurrent Events Trial (CARE): The Effect of Pravastatin on Coronary Events After Myocardial Infarction in Patients with Average Cholesterol LevelsFrank M. Sacks, Marc A. Pfeffer, Lemuel A. Moy?, C. Morton Hawkins, Barry R. Davis, Jean L. Rouleau, Thomas G. Cole, and Eugene BraunwaldLessons from the West of Scotland Coronary Prevention Study (WOSCOPS)James Shepherd and Allan GawProgram on the Surgical Control of the Hyperlipidemias (POSCH) Trial: A Pivotal 25-Year StudyHenry BuchwaldThe Air Force/Texas Atherosclerosis Prevention Study (AFCAPS/TexCAPS): Primary Prevention of Acute Major Coronary Events in Women and Men with Average CholesterolStephen Weis, Michael Clearfield, Lt. Col. John R. Downs, and Antonio M. Gotto, Jr.Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study: Clinical Implications for Cardiovascular PracticeAndrew M. Tonkin and David HuntAngiographic Results of Lipid-Lowering Trials: A Systematic Review and Meta-AnalysisCheryl L. Holmes, Michael Schulzer, and G. B. John ManciniBiochemical Correlates of Plaque Progression and Coronary EventsMelissa Ferraro-Borgida and David WatersLipid Therapy to Stabilize the Vulnerable Atherosclerotic Plaque: New Insights into the Prevention of Cardiovascular EventsB. Greg Brown and Xue-Qiao ZhaoCholesterol-Lowering Trials with Carotid Ultrasonographic OutcomesRobert P. ByingtonCholesterol Lowering Reduces Mortality: The StatinsDavid J. Gordon